Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASPEN AEROGELS INCASPN · Entity 5645 | Director | June 02, 2022 | June 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASPEN AEROGELS INC
Report date June 02, 2022 · Filed June 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 79,231 |
Reported balance
After 2022-06-02 transaction · row 1
1 source rowRow 1 · 2022-06-02 · Grant · Acquired 2,699 · Balance 79,231 F1: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.89 · Expires 2032-06-02 | Direct | 3,178 |
Reported balance
After 2022-06-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-06-02 · Grant · Acquired 3,178 · Balance 3,178 F2: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023.
F2: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AquaVenture Holdings Ltd
Report date March 30, 2020 · Filed March 30, 2020
Section 16 reporting ended · disclosed 2020-03-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-03-30 transaction · row 1
1 source rowRow 1 · 2020-03-30 · Disposition to issuer · Disposed 9,754 · Balance 0 F1: Pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated as of December 23, 2019, among Culligan International Company, a Delaware corporation ("Parent"), Amberjack Merger Sub Limited, a business company incorporated under the laws of the British Virgin Islands and a subsidiary of Parent ("Merger Sub"), and the Issuer, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Merger"). At the effective time of the Merger, each ordinary share outstanding, automatically and without any required action on the part of the Reporting Person, was converted into the right to receive $27.10 in cash, without interest. |
| Share OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $18.00 | Direct | 0 |
Reported balance
After 2020-03-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-03-30 · Disposition to issuer · Disposed 7,560 · Balance 0 F2: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each share option outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, was cancelled in exchange for the right to receive an amount in cash (without interest and subject to deduction for any applicable tax withholdings) equal to the excess, if any, of $27.10 over the per share exercise price of such share option. |
| Deferred Compensation - Phantom Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-03-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-03-30 · Disposition to issuer · Disposed 14,785 · Balance 0 F3: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each phantom share unit outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, became fully vested and was cancelled in exchange for a right to receive a cash payment in an amount equal to $27.10, without interest, for each ordinary share underlying the phantom share unit, less any required withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated as of December 23, 2019, among Culligan International Company, a Delaware corporation ("Parent"), Amberjack Merger Sub Limited, a business company incorporated under the laws of the British Virgin Islands and a subsidiary of Parent ("Merger Sub"), and the Issuer, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Merger"). At the effective time of the Merger, each ordinary share outstanding, automatically and without any required action on the part of the Reporting Person, was converted into the right to receive $27.10 in cash, without interest.
F2: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each share option outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, was cancelled in exchange for the right to receive an amount in cash (without interest and subject to deduction for any applicable tax withholdings) equal to the excess, if any, of $27.10 over the per share exercise price of such share option.
F3: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each phantom share unit outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, became fully vested and was cancelled in exchange for a right to receive a cash payment in an amount equal to $27.10, without interest, for each ordinary share underlying the phantom share unit, less any required withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2022 Filed Jun 6, 2022 23:11 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (Right-to-Buy) · Derivative | 3,178 | $0.00 Strike: $18.89 | $0.00 |
DisclosureSEC source: 0001209191-22-034704 · doc4.xml · derivative · entry 2 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,178 Underlying: Common Stock · 3,178 shares Expires 2032-06-02 F2 · derivative.exercise_date: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 23:11 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 2,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034704 · doc4.xml · nonDerivative · entry 1 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,231 F1 · shares: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:47 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (Right-to-Buy) · Derivative | 3,088 | $0.00 Strike: $20.49 | $0.00 |
DisclosureSEC source: 0001209191-21-037712 · doc4.xml · derivative · entry 2 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,088 Underlying: Common Stock · 3,088 shares Expires 2031-06-01 F2 · derivative.exercise_date: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 1, 2022, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2022. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:47 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 2,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037712 · doc4.xml · nonDerivative · entry 1 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,532 F1 · shares: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 1, 2022, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2022. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 20:36 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (right to buy · Derivative | 9,817 | $0.00 Strike: $6.79 | $0.00 |
DisclosureSEC source: 0001209191-20-038203 · doc4.xml · derivative · entry 2 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,817 Underlying: Common Stock · 9,817 shares Expires 2030-06-18 F2 · derivative.exercise_date: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 18, 2021 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2021. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 20:36 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 7,511 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-038203 · doc4.xml · nonDerivative · entry 1 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,043 F1 · shares: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 18, 2021 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2021. Read SEC document |
| March 30, 2020 Filed Mar 30, 2020 16:36 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | Disposition to issuerDeferred Compensation - Phantom Share Units · Derivative | 14,785 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-040415 · a4.xml · derivative · entry 3 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,785 shares Expires not disclosed F3 · derivative.exercise_price: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each phantom share unit outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, became fully vested and was cancelled in exchange for a right to receive a cash payment in an amount equal to $27.10, without interest, for each ordinary share underlying the phantom share unit, less any required withholding taxes. F3 · price: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each phantom share unit outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, became fully vested and was cancelled in exchange for a right to receive a cash payment in an amount equal to $27.10, without interest, for each ordinary share underlying the phantom share unit, less any required withholding taxes. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each phantom share unit outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, became fully vested and was cancelled in exchange for a right to receive a cash payment in an amount equal to $27.10, without interest, for each ordinary share underlying the phantom share unit, less any required withholding taxes. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each phantom share unit outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, became fully vested and was cancelled in exchange for a right to receive a cash payment in an amount equal to $27.10, without interest, for each ordinary share underlying the phantom share unit, less any required withholding taxes. Read SEC document |
| March 30, 2020 Filed Mar 30, 2020 16:36 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | Disposition to issuerShare Options · Derivative | 7,560 | Not disclosed Strike: $18.00 | Not disclosed |
DisclosureSEC source: 0001104659-20-040415 · a4.xml · derivative · entry 2 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,560 shares Expires not disclosed F2 · price: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each share option outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, was cancelled in exchange for the right to receive an amount in cash (without interest and subject to deduction for any applicable tax withholdings) equal to the excess, if any, of $27.10 over the per share exercise price of such share option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each share option outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, was cancelled in exchange for the right to receive an amount in cash (without interest and subject to deduction for any applicable tax withholdings) equal to the excess, if any, of $27.10 over the per share exercise price of such share option. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each share option outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, was cancelled in exchange for the right to receive an amount in cash (without interest and subject to deduction for any applicable tax withholdings) equal to the excess, if any, of $27.10 over the per share exercise price of such share option. Read SEC document |
| March 30, 2020 Filed Mar 30, 2020 16:36 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | Disposition to issuerOrdinary Shares | 9,754 | $27.10 | $264,333.40 |
DisclosureSEC source: 0001104659-20-040415 · a4.xml · nonDerivative · entry 1 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated as of December 23, 2019, among Culligan International Company, a Delaware corporation ("Parent"), Amberjack Merger Sub Limited, a business company incorporated under the laws of the British Virgin Islands and a subsidiary of Parent ("Merger Sub"), and the Issuer, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Merger"). At the effective time of the Merger, each ordinary share outstanding, automatically and without any required action on the part of the Reporting Person, was converted into the right to receive $27.10 in cash, without interest. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 21:18 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (right to buy) · Derivative | 11,950 | $0.00 Strike: $6.08 | $0.00 |
DisclosureSEC source: 0001209191-19-038580 · doc4.xml · derivative · entry 2 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,950 Underlying: Common Stock · 11,950 shares Expires 2029-06-19 F2 · derivative.exercise_date: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 19, 2020 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2020. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 21:18 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 8,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-038580 · doc4.xml · nonDerivative · entry 1 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,532 F1 · shares: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 19, 2020 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2020. Read SEC document |
| February 24, 2019 Filed Feb 26, 2019 17:03 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | GrantDeferred Compensation - Phantom Share Units · Derivative | 5,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-002632 · edgar.xml · derivative · entry 2 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,540 Underlying: Ordinary Shares · 5,540 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom share unit (which is in the form of a deferred compensation share unit) is the economic equivalent of one ordinary share of the Issuer. F2 · shares: Represents the number of phantom share units credited to the reporting person's deferred account pursuant to the Issuer's Independent Directors' Deferred Compensation Program (the "Program") which was established under the Issuer's 2016 Share Option and Incentive Plan (the "Plan"). The number of whole and fractional phantom share units credited to the reporting person's deferred account is equal to the number of Restricted Share Units that would otherwise be granted on such date. F3 · derivative.exercise_date: 100% of the phantom share units granted shall vest on February 24, 2020. Once vested, the phantom share units credited to the reporting person's deferred account shall be settled in ordinary shares upon the earlier of the reporting person's death, disability, separation from the board, sale event (as defined in the Plan) or December 31, 2021 F3 · derivative.expiration_date: 100% of the phantom share units granted shall vest on February 24, 2020. Once vested, the phantom share units credited to the reporting person's deferred account shall be settled in ordinary shares upon the earlier of the reporting person's death, disability, separation from the board, sale event (as defined in the Plan) or December 31, 2021 Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 20:34 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (right to buy) · Derivative | 13,517 | $0.00 Strike: $5.27 | $0.00 |
DisclosureSEC source: 0001209191-18-039223 · doc4.xml · derivative · entry 2 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,517 Underlying: Common Stock · 13,517 shares Expires 2028-06-20 F2 · derivative.exercise_date: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 20, 2019 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2019. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 20:34 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 9,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-039223 · doc4.xml · nonDerivative · entry 1 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,144 F1 · shares: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 20, 2019 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2019. Read SEC document |
| April 10, 2018 Filed Apr 10, 2018 18:45 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | Exercise / conversionRestricted Share Units · Derivative | 9,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-005565 · edgar.xml · derivative · entry 2 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,754 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Ordinary Share of the Company. F2 · derivative.exercise_date: The Restricted Share Units were issued pursuant to the Company's 2016 Share Option and Incentive Plan. 100% of the shares shall vest on April 10, 2018. F2 · derivative.expiration_date: The Restricted Share Units were issued pursuant to the Company's 2016 Share Option and Incentive Plan. 100% of the shares shall vest on April 10, 2018. Read SEC document |
| April 10, 2018 Filed Apr 10, 2018 18:45 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | Exercise / conversionOrdinary Shares | 9,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-005565 · edgar.xml · nonDerivative · entry 1 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 17:17 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | GrantDeferred Compensation - Phantom Share Unit · Derivative | 9,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003172 · edgar.xml · derivative · entry 1 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,245 Underlying: Ordinary Shares · 9,245 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom share unit (which is in the form of a deferred compensation share unit) is the economic equivalent of one ordinary share of the Issuer. F2 · shares: Represents the number of phantom share units credited to the reporting person's deferred account pursuant to the Issuer's Independent Directors' Deferred Compensation Program (the "Program") which was established under the Issuer's 2016 Share Option and Incentive Plan (the "Plan"). The number of whole and fractional phantom share units credited to the reporting person's deferred account is equal to the number of Restricted Share Units that would otherwise be granted on such date. F3 · derivative.exercise_date: 100% of the phantom share units granted shall vest on February 27, 2019. Once vested, the phantom share units credited to the reporting person's deferred account shall be settled in ordinary shares upon the earlier of the reporting person's death, disability, separation from the board, sale event (as defined in the Plan) or December 31, 2020. F3 · derivative.expiration_date: 100% of the phantom share units granted shall vest on February 27, 2019. Once vested, the phantom share units credited to the reporting person's deferred account shall be settled in ordinary shares upon the earlier of the reporting person's death, disability, separation from the board, sale event (as defined in the Plan) or December 31, 2020. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 21:29 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (right to buy) · Derivative | 17,019 | $0.00 Strike: $4.15 | $0.00 |
DisclosureSEC source: 0001209191-17-040221 · doc4.xml · derivative · entry 2 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,019 Underlying: Common Stock · 17,019 shares Expires 2027-06-14 F2 · derivative.exercise_date: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 14, 2018 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2018. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 21:29 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 12,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040221 · doc4.xml · nonDerivative · entry 1 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,467 F1 · shares: The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 14, 2018 or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2018. Read SEC document |
| April 10, 2017 Filed Apr 11, 2017 16:24 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | GrantRestricted Share Units · Derivative | 9,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-005933 · edgar.xml · derivative · entry 1 Reilly Richard F · CIK 0001610275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,754 Underlying: Ordinary Shares · 9,754 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Ordinary Share of the Company. F2 · derivative.exercise_date: The Restricted Share Units were issued pursuant to the Company's 2016 Share Option and Incentive Plan. 100% of the shares shall vest on April 10, 2018. F2 · derivative.expiration_date: The Restricted Share Units were issued pursuant to the Company's 2016 Share Option and Incentive Plan. 100% of the shares shall vest on April 10, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.